Covid 19: Statistical Improvement in Clinical Outcomes w/Quercetin
October 22, 2021 By Joseph Mercola

Two recent studies highlight the potential this safe plant-derived antioxidant has to treat COVID-19.


Outpatient Study

In the first study, published in the International Journal of General Medicine, 42 COVID-19 outpatients were divided into two groups. One group of 21 patients received standard medical therapy consisting of painkillers (acetaminophen) and an antibiotic for three consecutive days. The other 21 patients received standard therapy, plus the equivalent of 600 mg of quercetin per day (divided into three doses) for seven days, followed by another seven-day course of 400 mg of quercetin per day (divided into two doses).

The quercetin was used with sunflower lecithin, which has been demonstrated to increase absorption in the gut by as much as 20 times, compared to pure quercetin formulations.

The main outcomes being evaluated were virus clearance and symptoms. After one week of treatment, --16 of the 21 patients in the quercetin group tested negative for SARS-CoV-2 and 12 reported that all of their symptoms had diminished--.

In the standard care group, only two patients tested negative and four reported partially improved symptoms. By the end of week two, the five remaining patients in the quercetin group tested negative. In the standard care group, 17 of the 19 remaining patients tested negative and one had died.

“These results are impressive, and hopefully additional studies will be conducted on hospitalized patients to see how quercetin might be helpful in more severe cases,” Dr. Michael Murray wrote in an Aug. 21 newsletter.